Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
---|---|---|---|---|---|---|---|---|---|
Patent 7378508 was granted and assigned to Optimer Pharmaceuticals on May, 2008 by the United States Patent and Trademark Office. | 7378508 | May 27, 2008 | |||||||
Patent 7507564 was granted and assigned to Optimer Pharmaceuticals on March, 2009 by the United States Patent and Trademark Office. | 7507564 | March 24, 2009 | |||||||
Patent 7601695 was granted and assigned to Optimer Pharmaceuticals on October, 2009 by the United States Patent and Trademark Office. | 7601695 | October 13, 2009 | |||||||
Patent 8012943 was granted and assigned to Optimer Pharmaceuticals on September, 2011 by the United States Patent and Trademark Office. | 8012943 | September 6, 2011 | |||||||
Patent 8044030 was granted and assigned to Optimer Pharmaceuticals on October, 2011 by the United States Patent and Trademark Office. | 8044030 | October 25, 2011 | |||||||
Patent 7863249 was granted and assigned to Optimer Pharmaceuticals on January, 2011 by the United States Patent and Trademark Office. | 7863249 | January 4, 2011 | |||||||
Patent 7414885 was granted and assigned to Optimer Pharmaceuticals on August, 2008 by the United States Patent and Trademark Office. | 7414885 | August 19, 2008 | |||||||
Patent 7906489 was granted and assigned to Optimer Pharmaceuticals on March, 2011 by the United States Patent and Trademark Office. | 7906489 | March 15, 2011 | |||||||
Patent 8343936 was granted and assigned to Optimer Pharmaceuticals on January, 2013 by the United States Patent and Trademark Office. | 8343936 | January 1, 2013 |